ASCENDIS PHARMA A/S -
136.08
29-November-24 13:45:00
15 minutes delayed
Stocks
-0.23
-0.17%
Today's range
134.46 - 137.70
ISIN
N/A
Source
NASDAQ
-
14 Sep 2023 12:22:57 By Nasdaq GlobeNewswire
-
Ascendis Pharma Reports Second Quarter 2023 Financial Results
05 Sep 2023 16:03:00 By Nasdaq GlobeNewswire
-
05 Sep 2023 16:01:00 By Nasdaq GlobeNewswire
-
Ascendis Pharma and Royalty Pharma Enter into $150 Million Royalty Funding Agreement
05 Sep 2023 16:01:00 By Nasdaq GlobeNewswire
-
Ascendis Pharma A/S Announces Three Upcoming Investor Presentations
24 Aug 2023 08:30:00 By Nasdaq GlobeNewswire
-
15 Aug 2023 08:30:00 By Nasdaq GlobeNewswire
-
17 Jun 2023 17:30:00 By Nasdaq GlobeNewswire
-
Ascendis Pharma Showcases Its Latest Endocrinology Programs, Data, and Research at ENDO 2023
13 Jun 2023 09:21:55 By Nasdaq GlobeNewswire
-
Ascendis Pharma to Participate in the Goldman Sachs 44th Annual Global Healthcare Conference
07 Jun 2023 08:30:00 By Nasdaq GlobeNewswire
-
Ascendis Pharma Opens Compassionate Use Program for TransCon™ PTH (palopegteriparatide) in Germany
05 Jun 2023 17:30:09 By Nasdaq GlobeNewswire
-
Ascendis Pharma Oncology Program Update Highlights Latest Clinical Data for Product Candidates
31 May 2023 08:30:00 By Nasdaq GlobeNewswire
-
Ascendis Pharma to Host Oncology Program Update on May 31
25 May 2023 08:30:00 By Nasdaq GlobeNewswire
-
13 May 2023 19:00:00 By Nasdaq GlobeNewswire
-
Ascendis Pharma to Participate in the BofA Securities 2023 Health Care Conference
03 May 2023 16:15:00 By Nasdaq GlobeNewswire
-
01 May 2023 07:00:00 By Nasdaq GlobeNewswire
-
Ascendis Pharma Reports First Quarter 2023 Financial Results
27 Apr 2023 16:01:00 By Nasdaq GlobeNewswire
-
13 Apr 2023 08:30:00 By Nasdaq GlobeNewswire
-
03 Apr 2023 07:05:00 By Nasdaq GlobeNewswire
-
Ascendis Pharma Provides Update on Regulatory Reviews of TransCon PTH™ in Hypoparathyroidism
03 Apr 2023 07:00:00 By Nasdaq GlobeNewswire
-
Ascendis Pharma to Participate in the Oppenheimer 33rd Annual Healthcare Conference
10 Mar 2023 08:00:00 By Nasdaq GlobeNewswire